| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 06/10/2009 | CN100497392C Antagonistic anti-hTNFSF13b Human antibodies |
| 06/10/2009 | CN100497323C New heterocyclic oxime compounds, preparing process and medical composition thereof |
| 06/10/2009 | CN100497302C Diarylurea derivatives and their use as chloride channel blockers |
| 06/10/2009 | CN100496596C Improved Chinese medicinal paste for arthralgia and its preparation |
| 06/10/2009 | CN100496575C Plaster for treating protrusion of the lumber intervertebral discs |
| 06/10/2009 | CN100496542C Chinese traditional medicine composition for treating arthralgia syndrome of cervical spondylopathy and its preparation |
| 06/10/2009 | CN100496526C Preparation of soft capsule of Chinese traditional medicine for treating rheumatism and preparation method |
| 06/10/2009 | CN100496524C Bone-setting powdered medicine composition |
| 06/10/2009 | CN100496501C Pharmaceutical composition and methods comprising combinations of 2-alkylidene-19-nor-vitamin D derivatives and an estrogen agonist/antagonist |
| 06/09/2009 | US7545964 Methods and devices for quantitative analysis of x-ray images |
| 06/09/2009 | US7544853 C1 inhibitor with short half-life transient treatment |
| 06/09/2009 | US7544835 Carboxylic acid derivative and salt thereof |
| 06/09/2009 | US7544709 Derivatives of andrimide and moiramide B having antibacterial properties |
| 06/09/2009 | US7544703 N-(3,5-Dimethylphenyl)-2-[2-(4-methylpiperazin-1-yl)pyridin-4-ylmethylthio]pyridine-3-carboxamide; 2-(2-Cyclopropylaminopyridin-4-ylmethylthio)-N-(3,5-dimethylphenyl)pyridine-3-carboxamide; cancer, rheumatoid arthritis, age-related macular degeneration, diabetic retinopathy, retinopathy of prematurity |
| 06/09/2009 | US7544700 4-chloro-N-((5-((4-(hexylamino)piperidin-1-yl)sulfonyl)thien-2 -yl)methyl)benzamide for example; JUN kinase inhibitors to treat nervous system disorders, cancer, cardiovascular and autoimmune disorders |
| 06/09/2009 | US7544688 Hetereoaryl nitrile derivatives |
| 06/09/2009 | US7544684 Hydrazono-malonitriles |
| 06/09/2009 | US7544669 Polynucleotide therapy |
| 06/09/2009 | US7544655 Novel amino acid sequences are within the carboxy termini of fibrinogen; useful for cell culture and cell separation |
| 06/09/2009 | US7544519 Identifying modulators for prevention and treatment of infection, blood, metabolic, cell proliferative and respiratory system disorders |
| 06/09/2009 | US7544497 Modulating sirtuin deacetylase protein; apoptosis; using flavone, stilbene, isoflavone, sphingosine; stroke; cardiovascular disorders; antiarthritic agents; Alzheimer's disease |
| 06/09/2009 | US7544486 transfecting a mammalian cell with nucleic acid construct to express bone growth factor; implants; inducing osteogenic differentiation, osteoblastic mineralization and/or bone formation in clinical applications; lower doses of each growth factor hence cheaper; for treating bone disorders |
| 06/09/2009 | US7544359 Antiischemic agents; anticholesterol agents; cardiovascular disorders |
| 06/09/2009 | US7544357 Administering an interferon antagonist and a FMS-like tyrosine kinase 3 ("Flt3") ligand antagonist, such as an anti-IFN-alpha antibody; in vitro assay for determining risk for developing an autoimmune disease |
| 06/09/2009 | CA2410706C Composition and applicator for topical substance delivery |
| 06/09/2009 | CA2269083C Novel fgf homologs |
| 06/09/2009 | CA2251355C Il-6 mutein |
| 06/09/2009 | CA2251331C Calcilytic compounds |
| 06/09/2009 | CA2162900C New peptide derivatives |
| 06/04/2009 | WO2009070378A1 Compositions and methods for inhibiting the activation of dsrna-dependent protein kinase and tumor growth inhibition |
| 06/04/2009 | WO2009070116A1 A quinoline derivative acting as a p2x7-receptor antagonist |
| 06/04/2009 | WO2009069838A1 A composition for promoting osteoblast differentiation comprising berberine. |
| 06/04/2009 | WO2009069736A1 Nitrogenated compound |
| 06/04/2009 | WO2009069704A1 Lactic acid bacterium having effect of lowering blood uric acid level |
| 06/04/2009 | WO2009068567A1 C2-c5-alkyl-imidazole-bisphosphonates |
| 06/04/2009 | WO2009067820A1 14-3-3 antagonists for the prevention and treatment of arthritis |
| 06/04/2009 | WO2009067811A1 14-3-3 eta antibodies and uses thereof for the diagnosis and treatment of arthritis |
| 06/04/2009 | WO2009034452A3 Compound and device for treating bone and/or cartilage defects |
| 06/04/2009 | WO2009022179A3 Glucokinase activators in the treatment of osteoarthritis |
| 06/04/2009 | WO2009019503A3 P2x7 antagonists for use in the treatment of mood disorders |
| 06/04/2009 | US20090143568 Recombinant gelatins |
| 06/04/2009 | US20090143483 Therapeutic or preventive drug for osteoporosis comprising isotaxiresinol derived from taxus yunnanensis |
| 06/04/2009 | US20090143469 Salts of nateglinide |
| 06/04/2009 | US20090143462 Products of Tetrahydrocannabinol, Compositions Comprising Prodrugs of Tetrahydrocannabinol and Methods of Using the Same |
| 06/04/2009 | US20090143455 Pyrazoles Useful in the Treatment of Inflammation |
| 06/04/2009 | US20090143421 Use of 2-benzoyl-imidazopyridines in therapeutics |
| 06/04/2009 | US20090143386 Human adam-10 inhibitors |
| 06/04/2009 | US20090143354 P2X7 Receptor Antagonists and Their Use |
| 06/04/2009 | US20090143337 C2-C5-Alkyl-Imidazole-Bisphosphonates |
| 06/04/2009 | US20090143319 Transcription factor decoy |
| 06/04/2009 | US20090143315 Salix extract, its use and formulations containing it |
| 06/04/2009 | US20090143309 converting an agonist of protein kinase C to an antagonist of protein kinase C; amino acid sequences; crosslinked via an N-terminal Cys-Cys bond to a peptide to facilitate transport cellular uptake |
| 06/04/2009 | US20090143297 Modulators of antiestrogen pharmacology |
| 06/04/2009 | US20090142782 Using actinobacillus specific immunogolbulins to diagnose gum disease |
| 06/04/2009 | US20090142419 Anti-inflammatory extract and agent and method for the production thereof |
| 06/04/2009 | US20090142385 Compositions for treating bone defects |
| 06/04/2009 | US20090142375 Lipoteichoic acid from lactic acid bacteria and its use to modulate immune responses madiated by gram-negative bacteria, potential pathogenic gram-positive bacteria |
| 06/04/2009 | US20090142349 CD19 Antibodies And Their uses |
| 06/04/2009 | US20090142329 Interleukin-1 Beta Converting Enzyme Like Apoptosis Protease-3 and 4 |
| 06/04/2009 | US20090142310 Method of treating inflammatory arthropathies with suppressors of cpg oligonucleotides |
| 06/04/2009 | US20090142295 Anti-Connexin Compounds and Uses Thereof |
| 06/04/2009 | US20090142278 Effervescent Compositions Comprising Phosphonates and Methods Related Thereto |
| 06/04/2009 | CA2851018A1 Lactic acid bacteria having action of lowering blood uric acid level |
| 06/04/2009 | CA2707187A1 Lactic acid bacterium having effect of lowering blood uric acid level |
| 06/04/2009 | CA2706656A1 Compositions and methods for inhibiting the activation of dsrna-dependent protein kinase and tumor growth inhibition |
| 06/04/2009 | CA2706479A1 14-3-3 antagonists for the prevention and treatment of arthritis |
| 06/04/2009 | CA2706476A1 14-3-3 eta antibodies and uses thereof for the diagnosis and treatment of arthritis |
| 06/04/2009 | CA2701516A1 C2-c5-alkyl-imidazole-bisphosphonates |
| 06/03/2009 | EP2065053A1 Cell death inhibitor |
| 06/03/2009 | EP2065050A1 Methods of treating multiple myeloma and myeloma-induced bone resorption using integrin antagonists |
| 06/03/2009 | EP2064184A1 Multimeric heterocyclic compounds useful as neutrophil elastase inhibitors |
| 06/03/2009 | EP2063962A2 Irak modulators for treating an inflammatory condition, cell proliferative disorder, immune disorder |
| 06/03/2009 | EP2063879A2 Compositions of chk1 inhibitors and cyclodextrin |
| 06/03/2009 | EP1682546B1 Peptidomimetic compounds, stereoselective process for their preparation, their use as biologically active synthetic intermediates |
| 06/03/2009 | EP1435906B1 Method for producing biologically active products |
| 06/03/2009 | EP1399440B1 5-(2-aminopyrimidin-4-yl)benzisoxazoles as protein kinase inhibitors |
| 06/03/2009 | EP1313737B1 Novel guanidino derivatives as inhibitors of cell adhesion |
| 06/03/2009 | EP1187636B1 Injectable hyaluronate-sulfated polysaccharide conjugates |
| 06/03/2009 | CN101445504A Dioxane-2-alkyl carbamates derivatives |
| 06/03/2009 | CN101444509A Triple monoamine reuptake inhibitors for the treatment of chronic pain |
| 06/03/2009 | CN100494182C Regulatory factor of tumor necrosis alpha factor |
| 06/03/2009 | CN100493617C Recombinant adeno-associated virus for prevention and cure of I-type diabetes and use thereof |
| 06/02/2009 | US7541378 tert-butyl 3-amino-1H-thieno[2,3-c]pyrazole-5-carboxylate; N-benzyl-3-[(4-fluorobenzoyl)amino]-1H-thieno[2,3-c]pyrazole-5-carboxamide; treats a disease caused associated with an altered (disregulated) protein kinase activity e.g cancer, cell proliferative disorders, Alzheimer's disease, viral infections |
| 06/02/2009 | US7541375 Azole derivatives and pharmaceutical compositions containing them |
| 06/02/2009 | US7541369 Amino-derivatives as novel inhibitors of histone deacetylase |
| 06/02/2009 | US7541363 (E)-8-(3,4-dimethoxystyryl)-1,3-diethyl-7-methyl-3,7-dihydro-1H-purine-2,6-dione; excellent solubility, stability, bioavailability, dispersing property; adenosine A2 receptor antagonistic activity; treats Parkinson disease, senile dementia, depression, asthma and osteoporosis |
| 06/02/2009 | US7541362 7-(3,4-Dichlorophenyl)-4,7-dihydro-5-methyl-6-(5-phenyl-2-oxazolyl)pyrazolo[1, 5-a]pyrimidine |
| 06/02/2009 | US7541354 Bicyclo-pyrazoles |
| 06/02/2009 | US7541341 2-(4-ethylbenzyl)-5-hydroxymethylphenyl 6-O-ethoxycarbonyl- beta -D-glucopyranoside; for treatment/prevention of hyperglycemia associated with diabetes/obesity |
| 06/02/2009 | US7541154 GASP1: a follistatin domain containing protein |
| 06/02/2009 | US7541033 Humanized anti-IL-1β antibodies |
| 06/02/2009 | US7541031 Methods for treating rheumatoid arthritis using human antibodies that bind human TNFα |
| 06/02/2009 | CA2371728C High dose radionuclide complexes for bone marrow suppression |
| 06/02/2009 | CA2258539C Ring-fused dihydropyranes, process for the preparation and use thereof |
| 05/28/2009 | WO2009067273A1 Pde5 inhibitors for treating pain caused by osteoarthritis |
| 05/28/2009 | WO2009067177A2 Bone morphogenic protein binding peptide |
| 05/28/2009 | WO2009066775A1 Amorphous form of heterocyclic compound, solid dispersion and medicinal preparation each comprising the same, and process for production of the same |
| 05/28/2009 | WO2009066283A2 Calcium-mediated effects of coral and methods of use thereof |
| 05/28/2009 | WO2009066107A1 Use of a nicotinic receptor agonist |
| 05/28/2009 | WO2009065946A2 Pharmaceutical kit consisting of an oil-in-water emulsion and a solid composition |